Cargando…

Impact of COVID-19 lockdown in patients with implantable cardioverter and cardiac resynchronization therapy defibrillators: insights from daily remote monitoring transmissions

In Italy, a strict lockdown was imposed from 8 March 2020 to stop the spread of the coronavirus disease 2019 (COVID-19). We explored the effect of this lockdown on data transmitted by remote monitoring (RM) of implantable cardioverter and cardiac resynchronization therapy defibrillators (ICDs/CRT-Ds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mascioli, Giosuè, Lucca, Elena, Napoli, Paola, Giacopelli, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006504/ https://www.ncbi.nlm.nih.gov/pubmed/33779824 http://dx.doi.org/10.1007/s00380-021-01843-w

Ejemplares similares

Remote monitoring temporal trends during COVID-19 pneumonia in patients with implanted defibrillators
por: Mascioli, Giosuè, et al.
Publicado: (2021)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
por: Braunschweig, Frieder, et al.
Publicado: (2019)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review
por: De Maria, Elia, et al.
Publicado: (2017)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Atrial signal amplitude predicts atrial high‐rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions
por: Zecchin, Massimo, et al.
Publicado: (2020)

Radiofrequency remote monitor software patch update without cybersecurity implantable cardioverter-defibrillator firmware update increases the risk of inappropriate implantable cardioverter-defibrillator therapies
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Impact of the COVID‐19 lockdown on the arrhythmic burden of patients with implantable cardioverter‐defibrillators
por: Sassone, Biagio, et al.
Publicado: (2021)

Contributions of remote monitoring to the follow-up of implantable cardioverter–defibrillator leads under advisory
por: Guédon-Moreau, Laurence, et al.
Publicado: (2010)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantation of single lead cardioverter defibrillator with floating atrial sensing dipole in a pregnant patient without using fluoroscopy
por: Quartieri, Fabio, et al.
Publicado: (2016)

Implantation of a Resynchronization Implantable Cardioverter Defibrillator in a Patient with Persistent Left Superior Vena Cava
por: Antonelli, Dante, et al.
Publicado: (2007)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Remote monitoring of implantable cardioverters defibrillators: a comparison of acceptance between octogenarians and younger patients
por: Safarikova, Iva, et al.
Publicado: (2020)

Age, Sex, and Remote Monitoring Differences in Device Acceptance for Patients With Implanted Cardioverter Defibrillators in Canada
por: Ng, Jessica, et al.
Publicado: (2020)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Editorial to implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Minamiguchi, Hitoshi
Publicado: (2019)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study
por: Guédon-Moreau, Laurence, et al.
Publicado: (2014)

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
por: Barakpour, Hamid, et al.
Publicado: (2009)

A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
por: Tomini, F., et al.
Publicado: (2016)

The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives
por: Landolina, Maurizio, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s95fa2q56rt9hpjrdj03t2h9cv